hnRNPA2/B1 is an oncogene in gliomas; inhibiting its expression leads to the inactivation of the AKT and STAT3 signaling pathways, which inhibit proliferation and enhance apoptosis in U251 glioma cells [87]. Here, AKT1 is linked to central nervous system cancer.